4 Einträge gefunden

1. Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma

   1. Remke, Marc
   2. Hering, Esther
   3. Gerber, Nicolas U
   4. Kool, Marcel
   5. Sturm, Dominik
   6. Rickert, Christian H
   7. Gerß, Joachim

   2013 - Forschungsinformationssystem des UKE
2. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.

   1. Remke, Marc
   2. Hielscher, Thomas
   3. Korshunov, Andrey
   4. Northcott, Paul A
   5. Bender, Sebastian
   6. Kool, Marcel
   7. Westermann, Frank

   2011 - Forschungsinformationssystem des UKE
3. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.

   1. Pfaff, Elke
   2. Remke, Marc
   3. Sturm, Dominik
   4. Benner, Axel
   5. Witt, Hendrik
   6. Till, Milde
   7. von Bueren, André

   2010 - Forschungsinformationssystem des UKE
4. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.

   1. Korshunov, Andrey
   2. Remke, Marc
   3. Werft, Wiebke
   4. Benner, Axel
   5. Ryzhova, Marina
   6. Witt, Hendrik
   7. Sturm, Dominik

   2010 - Forschungsinformationssystem des UKE